Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection - PubMed (original) (raw)

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

Julia H Arnsten et al. AIDS. 2007.

Abstract

Background: Osteopenia has been described in HIV-infected persons, but most studies have not focused on aging men, have not included an HIV-negative comparison group with similar risks to those of the HIV-infected men, or lacked data on fracture rates.

Methods: We analyzed bone mineral density (BMD) and incident fractures in 559 men who were >or= 49 years old with or at-risk for HIV, including 328 with and 231 without HIV infection.

Results: Median age was 55 years, 56% were black and 89% had used illicit drugs. In unadjusted analysis, BMD was lower in HIV-infected compared with HIV-uninfected men at the femoral neck (0.97 +/- 0.14 versus 1.00 +/- 0.15 g/cm; P < 0.05) and lumbar spine (1.17 +/- 0.20 versus 1.20 +/- 0.21 g/cm; P = 0.06); both differences were significant (P < 0.05) after adjusting for age, weight, race, testosterone level, and prednisone and illicit drug use. Non-black race and body weight were independently associated with BMD at both measurement sites and methadone therapy was independently associated with spine BMD. Among HIV-infected men, 87% had taken antiretrovirals and 74% had taken protease inhibitors, but their use was not associated with BMD. Among men who had at least one subsequent study visit (94%), incident fracture rates per 100 person-years differed among men with normal BMD, osteopenia and osteoporosis (1.4 versus 3.6 versus 6.5; P < 0.01). A 38% increase in fracture rate among HIV-infected men was not statistically significant.

Conclusions: HIV infection is independently associated with modestly reduced BMD in aging men, and decreased BMD is associated with increased fracture risk.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Slemenda C, Hui SL, Longcope C, Johnson CC. Sex steroids and bone mass: A study of changes about the time of menopause. J Clin Invest. 1987;80:1261–1269. - PMC - PubMed
    1. Manolagas SC, Jilka RL. Mechanisms of disease: Bone marrow, cytokines, and bone remodeling – emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305–311. - PubMed
    1. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178–208. - PubMed
    1. Rizzoli R, Bonjour JP. Determinants of peak bone mass and mechanisms of bone loss. Osteoporosis Intl. 1999;9(Suppl 2):S17–S23. - PubMed
    1. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315:841–846. - PMC - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources